{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:31:20Z","timestamp":1768717880963,"version":"3.49.0"},"reference-count":266,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The challenges of childhood uveitis lie in the varied spectrum of its clinical presentation, the often asymptomatic nature of disease, and the evolving nature of the phenotype alongside normal physiological development. These issues can lead to delayed diagnosis which can cause significant morbidity and severe visual impairment. The most common ocular complications include cataracts, band keratopathy, glaucoma, and macular oedema, and the various associated systemic disorders can also result in extra-ophthalmic morbidity. Pediatricians have an important role to play. Their awareness of the various presentations and etiologies of uveitis in children afford the opportunity of prompt diagnosis before complications arise. Juvenile Idiopathic Arthritis (JIA) is one of the most common associated disorders seen in childhood uveitis, but there is a need to recognize other causes. In this review, different causes of uveitis are explored, including infections, autoimmune and autoinflammatory disease. As treatment is often informed by etiology, pediatricians can ensure early ophthalmological referral for children with inflammatory disease at risk of uveitis and can support management decisions for children with uveitis and possible underling multi-system inflammatory disease, thus reducing the risk of the development of irreversible sequelae.<\/jats:p>","DOI":"10.3389\/fped.2022.874711","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:38:15Z","timestamp":1659332295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Pediatric uveitis: Role of the pediatrician"],"prefix":"10.3389","volume":"10","author":[{"given":"Abhay","family":"Shivpuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Turtsevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameenat Lola","family":"Solebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Compeyrot-Lacassagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1136\/bjo.86.1.51","article-title":"An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood","volume":"86","author":"Edelsten","year":"2002","journal-title":"Br J Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.survophthal.2021.06.006","article-title":"Pediatric uveitis: a comprehensive review","volume":"67","author":"Maleki","year":"2022","journal-title":"Surv Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"721953","DOI":"10.3389\/fmed.2021.721953","article-title":"The cellular composition of the uveal immune environment","volume":"8","author":"Reekie","year":"2021","journal-title":"Front Med."},{"key":"B4","first-page":"711","article-title":"Uveitis: the collaborative diagnostic evaluation","volume":"90","author":"Harman","year":"2014","journal-title":"Am Fam Physician."},{"key":"B5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.5811\/westjem.2016.12.31798","article-title":"Differentiating urgent and emergent causes of acute red eye for the emergency physician","volume":"18","author":"Gilani","year":"2017","journal-title":"West J Emerg Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.mcna.2016.12.013","article-title":"Ocular emergencies: red eye","volume":"101","author":"Tarff","year":"2017","journal-title":"Med Clin North Am."},{"key":"B7","first-page":"137","article-title":"Diagnosis and management of red eye in primary care","volume":"81","author":"Cronau","year":"2010","journal-title":"Am Fam Physician."},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.survophthal.2007.12.003","article-title":"Eye manifestations of intrauterine infections and their impact on childhood blindness","volume":"53","author":"Mets","year":"2008","journal-title":"Surv Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/ICU.0000000000000618","article-title":"Ocular manifestations of herpes simplex virus","volume":"30","author":"Valerio","year":"2019","journal-title":"Curr Opin Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","article-title":"Ocular toxoplasmosis: clinical features and prognosis of 154 patients","volume":"109","author":"Bosch-Driessen","year":"2002","journal-title":"Ophthalmology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"106180","DOI":"10.1016\/j.actatropica.2021.106180","article-title":"Ocular toxoplasmosis, an overview focusing on clinical aspects","volume":"225","author":"Fabiani","year":"2022","journal-title":"Acta Trop."},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08820530500231961","article-title":"Toxoplasmosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/09273948.2013.855799","article-title":"The manchester uveitis clinic: the first 3000 patients\u2013epidemiology and casemix","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul Immunol Inflamm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.survophthal.2021.06.003","article-title":"Ocular syphilis","volume":"67","author":"Furtado","year":"2022","journal-title":"Surv Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1442-9071.2010.02203.x","article-title":"Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients","volume":"38","author":"Amaratunge","year":"2010","journal-title":"Clin Exp Ophthalmol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","article-title":"Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1","volume":"135","author":"Agrawal","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2019.1646774","article-title":"Tubercular uveitis: nuggets from collaborative ocular tuberculosis study (COTS)-1","volume-title":"Ocul Immunol Inflamm","author":"Testi","year":"2019"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/09273948.2014.1004016","volume":"23","author":"Cunningham","year":"2015","journal-title":"Ocul Immunol Inflamm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1442-9071.2012.02766.x","article-title":"Clinical signs of uveitis associated with latent tuberculosis","volume":"40","author":"Ang","year":"2012","journal-title":"Clin Exp Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","article-title":"Ocular signs predictive of tubercular uveitis","volume":"149","author":"Gupta","year":"2010","journal-title":"Am J Ophthalmol."},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2020.1761400","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational review of 165 patients with tubercular anterior uveitis","volume-title":"Ocul Immunol Inflamm","author":"Agrawal","year":"2020"},{"key":"B22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ophtha.2021.08.008","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ophtha.2021.03.024","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0161-6420(00)00002-6","article-title":"Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis","volume":"107","author":"Suhler","year":"2000","journal-title":"Ophthalmology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICO.0b013e3181fb7fe8","article-title":"Cat-scratch uveitis confirmed by histological, serological, and molecular diagnoses","volume":"30","author":"Font","year":"2011","journal-title":"Cornea."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1016\/j.ophtha.2013.02.006","article-title":"Molecular diagnosis and ocular imaging of West Nile virus retinitis and neuroretinitis","volume":"120","author":"Sivakumar","year":"2013","journal-title":"Ophthalmology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ophtha.2006.04.021","article-title":"Ocular features of west nile virus infection in North America: a study of 14 eyes","volume":"113","author":"Chan","year":"2006","journal-title":"Ophthalmology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1217341","article-title":"Leptospiral uveitis: usefulness of clinical signs as diagnostic predictors","volume":"26","author":"Sivakumar","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/0956462415588444","article-title":"Uveitis secondary to leishmaniasis immune reconstitution syndrome in a HIV-positive patient","volume":"27","author":"Davies","year":"2016","journal-title":"Int J STD AIDS."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e02851","DOI":"10.7554\/eLife.02851","article-title":"Global distribution maps of the leishmaniases","volume":"3","author":"Pigott","year":"2014","journal-title":"Elife"},{"key":"B31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1473-3099(15)00489-2","article-title":"Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study","volume":"16","author":"Mattia","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/ceo.13450","article-title":"Emerging infectious uveitis: Chikungunya, dengue, Zika and Ebola: a review","volume":"47","author":"Oliver","year":"2019","journal-title":"Clin Exp Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/ICU.0000000000000426","article-title":"An update on ocular complications of Ebola virus disease","volume":"28","author":"Shantha","year":"2017","journal-title":"Curr Opin Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1056\/NEJMc1603618","article-title":"Uveitis associated with zika virus infection","volume":"375","author":"Furtado","year":"2016","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(16)32518-1","article-title":"Bilateral posterior uveitis associated with Zika virus infection","volume":"389","author":"Kodati","year":"2017","journal-title":"Lancet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jamaophthalmol.2016.0267","article-title":"Ocular findings in infants with microcephaly associated with presumed zika virus congenital infection in Salvador, Brazil","volume":"134","author":"de Paula Freitas","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/jamaophthalmol.2020.5131","article-title":"Association of anterior uveitis with acute zika virus infection in adults","volume":"139","author":"Troumani","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0008-4182(06)80028-1","article-title":"Bilateral acute anterior uveitis as a presenting symptom of Mycoplasma pneumoniae infection","volume":"41","author":"Weinstein","year":"2006","journal-title":"Can J Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jaapos.2016.02.005","article-title":"Bilateral intermediate uveitis with appearance of frosted branch angiitis and association with Mycoplasma pneumoniae infection: case report and review of the literature","volume":"20","author":"Matsou","year":"2016","journal-title":"J AAPOS."},{"key":"B40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1136\/bjophthalmol-2017-310251","article-title":"Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre","volume":"102","author":"Bernard","year":"2018","journal-title":"Br J Ophthalmol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1177\/1120672119856943","article-title":"Lyme-associated uveitis: clinical spectrum and review of literature","volume":"30","author":"Bernard","year":"2020","journal-title":"Eur J Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"NP151","DOI":"10.1177\/1120672120962055","article-title":"Lyme disease atypically presenting with a singular symptom: unilateral chorioretinitis","volume":"31","author":"Havuz","year":"2021","journal-title":"Eur J Ophthalmol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/bjo.2007.133405","article-title":"Ocular candidiasis: a review","volume":"92","author":"Shah","year":"2008","journal-title":"Br J Ophthalmol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"208847","DOI":"10.1136\/bcr-2014-208847","article-title":"Chronic candida endophthalmitis as a cause of intermediate uveitis","volume":"2015","author":"Amin","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cid\/cir355","article-title":"Ocular manifestations of candidemia","volume":"53","author":"Oude Lashof","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/jamaophthalmol.2018.6185","article-title":"Association of ocular inflammation and rubella virus persistence","volume":"137","author":"Gonzales","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ajo.2008.04.011","article-title":"Rubella virus-associated uveitis: clinical manifestations and visual prognosis","volume":"146","author":"de Visser","year":"2008","journal-title":"Am J Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5301\/ejo.5000673","article-title":"A therapeutic trial of valganciclovir in patients with uveitis and positive Epstein-Barr virus early antigen D IgG titers","volume":"26","author":"Boonsopon","year":"2016","journal-title":"Eur J Ophthalmol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12886-019-1090-5","article-title":"Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection","volume":"19","author":"Takahashi","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12985-020-01409-8","article-title":"Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis","volume":"17","author":"Xiao","year":"2020","journal-title":"Virol J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1258\/0956462991913925","article-title":"Symptomatic anterior uveitis in HIV-positive patients","volume":"10","author":"Verma","year":"1999","journal-title":"Int J STD AIDS."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ophtha.2012.01.030","article-title":"Clinical manifestations of human immunodeficiency virus-induced uveitis","volume":"119","author":"Kunavisarut","year":"2012","journal-title":"Ophthalmology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","article-title":"Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients","volume":"114","author":"van Boxtel","year":"2007","journal-title":"Ophthalmology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","article-title":"Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients","volume":"145","author":"Chee","year":"2008","journal-title":"Am J Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/aos.13877","article-title":"Uveitis causes according to immune status of patients","volume":"97","author":"Rothova","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/OPTO.S72079","article-title":"Diagnosis and treatment of anterior uveitis: optometric management","volume":"8","author":"Harthan","year":"2016","journal-title":"Clin Optom."},{"key":"B57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5507\/bp.2019.036","article-title":"Infectious uveitis in immunodeficient HIV-negative patients: a retrospective study","volume":"164","author":"Svozilkova","year":"2020","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"B58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ajo.2007.06.034","article-title":"Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis","volume":"144","author":"Westeneng","year":"2007","journal-title":"Am J Ophthalmol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/ICU.0000000000000530","article-title":"Drug-induced uveitis","volume":"29","author":"Moorthy","year":"2018","journal-title":"Curr Opin Ophthalmol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18502\/jovr.v16i1.8254","article-title":"Medication-induced uveitis: an update","volume":"16","author":"Iqbal","year":"2021","journal-title":"J Ophthalmic Vis Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archopht.1997.01100150735008","article-title":"Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis","volume":"115","author":"Davis","year":"1997","journal-title":"Arch Ophthalmol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archopht.1994.01090210043015","article-title":"Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin","volume":"112","author":"Saran","year":"1994","journal-title":"Arch Ophthalmol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/8756-3282(95)00448-3","article-title":"Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy","volume":"18","author":"Sauty","year":"1996","journal-title":"Bone."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Engl J Med."},{"key":"B65","article-title":"Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort","volume-title":"Retina","author":"Fraunfelder","year":"2009"},{"key":"B66","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1600-0420.1997.tb00783.x","article-title":"Bilateral anterior uveitis and retinal haemorrhages after administration of trimethoprim","volume":"75","author":"Kristinsson","year":"1997","journal-title":"Acta Ophthalmol Scand."},{"key":"B67","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13023-017-0677-2","article-title":"Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors","volume":"12","author":"Okafor","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"B68","first-page":"48","article-title":"Vaccine-associated uveitis","volume":"113","author":"Benage","year":"2016","journal-title":"Mo Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e1035","DOI":"10.1542\/peds.2012-2930","article-title":"Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl","volume":"132","author":"Ferrini","year":"2013","journal-title":"Pediatrics."},{"key":"B70","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","volume":"27","author":"Cunningham","year":"2019","journal-title":"Ocul Immunol Inflamm."},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2022.2058964","article-title":"COVID-19 vaccination and uveitis: epidemiology, clinical features and visual prognosis","volume-title":"Ocul Immunol Inflamm","author":"Ferrand","year":"2022"},{"key":"B72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13023-020-1324-x","article-title":"Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis","volume":"15","author":"Jari","year":"2020","journal-title":"Orphanet J Rare Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/children8080646","article-title":"Juvenile idiopathic arthritis associated uveitis","volume":"8","author":"Carlsson","year":"2021","journal-title":"Children"},{"key":"B74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12969-015-0018-8","article-title":"Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis","volume":"13","author":"Angeles-Han","year":"2015","journal-title":"Pediatr Rheumatol Online J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3899\/jrheum.191085","article-title":"Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a population-based nationwide study in Germany","volume":"48","author":"Walscheid","year":"2021","journal-title":"J Rheumatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3899\/jrheum.160717","article-title":"The juvenile psoriatic arthritis cohort in the CARRA registry: clinical characteristics, classification, and outcomes","volume":"44","author":"Zisman","year":"2017","journal-title":"J Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/ard.59.1.67","article-title":"Characterisation of uveitis in patients with psoriatic arthritis","volume":"59","author":"Paiva","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis."},{"key":"B79","first-page":"2370","article-title":"Visual prognosis in children with chronic anterior uveitis and arthritis","volume":"21","author":"Cabral","year":"1994","journal-title":"J Rheumatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.3899\/jrheum.100090","article-title":"Early predictors of juvenile sacroiliitis in enthesitis-related arthritis","volume":"37","author":"Pagnini","year":"2010","journal-title":"J Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/1744666X.2019.1593139","article-title":"Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice","volume":"15","author":"Haasnoot","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3109\/09273948.2016.1167224","article-title":"Clinical features of ocular sarcoidosis in patients with biopsy-proven pulmonary sarcoidosis in Serbia","volume":"25","author":"Radosavljevic","year":"2017","journal-title":"Ocul Immunol Inflamm."},{"key":"B83","first-page":"237","article-title":"Ocular and systemic features of sarcoidosis and correlation with the International Workshop for Ocular Sarcoidosis diagnostic criteria","volume":"32","author":"Agrawal","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/MCP.0000000000000409","article-title":"Ocular sarcoidosis: new diagnostic modalities and treatment","volume":"23","author":"Yang","year":"2017","journal-title":"Curr Opin Pulm Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.prrv.2018.05.003","article-title":"Paediatric sarcoidosis","volume":"29","author":"Nathan","year":"2019","journal-title":"Paediatr Respir Rev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e047059","DOI":"10.1136\/bmjopen-2020-047059","article-title":"Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey","volume":"11","author":"Wente-Schulz","year":"2021","journal-title":"BMJ Open."},{"key":"B88","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00467-016-3394-5","article-title":"Tubulointerstitial nephritis: diagnosis, treatment, and monitoring","volume":"32","author":"Joyce","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4586532","DOI":"10.1155\/2018\/4586532","article-title":"Clinical and genetic features of tubulointerstitial nephritis and uveitis syndrome with long-term follow-up","volume":"2018","author":"Kanno","year":"2018","journal-title":"J Ophthalmol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/ICU.0000000000000421","article-title":"Tubulointerstitial nephritis and uveitis","volume":"28","author":"Pakzad-Vaezi","year":"2017","journal-title":"Curr Opin Ophthalmol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","article-title":"The 2009 prospective multi-center epidemiologic survey of uveitis in Japan","volume":"56","author":"Ohguro","year":"2012","journal-title":"Jpn J Ophthalmol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/ijms21134690","article-title":"New biomarkers in acute tubulointerstitial nephritis: a novel approach to a classic condition","volume":"21","author":"Martinez Valenzuela","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/TCRM.S232660","article-title":"Behcet's disease in children: diagnostic and management challenges","volume":"16","author":"Costagliola","year":"2020","journal-title":"Ther Clin Risk Manag."},{"key":"B94","doi-asserted-by":"publisher","first-page":"627192","DOI":"10.3389\/fmed.2021.627192","article-title":"Pediatric Behcet's disease","volume":"8","author":"Yildiz","year":"2021","journal-title":"Front Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.ajo.2008.05.043","article-title":"Uveitis associated with pediatric beh\u00e7et disease in the american midwest","volume":"146","author":"Kesen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"653539","DOI":"10.1155\/2014\/653539","article-title":"Immunopathogenesis of ocular Behcet's disease","volume":"2014","author":"Park","year":"2014","journal-title":"J Immunol Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jfo.2019.02.002","article-title":"Eye and Behcet's disease","volume":"42","author":"Ksiaa","year":"2019","journal-title":"J Fr Ophtalmol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12348-019-0181-z","article-title":"Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis","volume":"9","author":"Ho","year":"2019","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"B99","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-019-0333-6","article-title":"Early administration of adalimumab for paediatric uveitis due to Behcet's disease","volume":"17","author":"Hiyama","year":"2019","journal-title":"Pediatr Rheumatol Online J."},{"key":"B100","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/adc.88.10.938","article-title":"Acute panuveitis and Takayasu's arteritis","volume":"88","author":"Kausman","year":"2003","journal-title":"Arch Dis Child."},{"key":"B101","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10016-004-0178-3","article-title":"Takayasu's arteritis presenting as uveitis in a 5-year-old girl","volume":"19","author":"Becker","year":"2005","journal-title":"Ann Vasc Surg."},{"key":"B102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13075-018-1643-7","article-title":"Extravascular manifestations of Takayasu arteritis: focusing on the features shared with spondyloarthritis","volume":"20","author":"Kwon","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12098-014-1367-x","article-title":"Acute anterior uveitis as the presenting feature of Kawasaki disease","volume":"81","author":"Madhusudan","year":"2014","journal-title":"Indian J Pediatr."},{"key":"B104","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3345\/kjp.2015.58.10.374","article-title":"Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease","volume":"58","author":"Choi","year":"2015","journal-title":"Korean J Pediatr."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1007\/s00296-011-2087-4","article-title":"Henoch-Schonlein purpura with uveitis: an unusual case and review of literature","volume":"32","author":"Kaur","year":"2012","journal-title":"Rheumatol Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/bjo.2004.064519","article-title":"Henoch-Schonlein purpura with keratitis and granulomatous anterior uveitis","volume":"89","author":"Muqit","year":"2005","journal-title":"Br J Ophthalmol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations","volume":"5","author":"Kubaisi","year":"2016","journal-title":"Intractable Rare Dis Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40123-019-0176-8","article-title":"Ocular manifestations of granulomatosis with polyangiitis: a review of the literature","volume":"8","author":"Sfiniadaki","year":"2019","journal-title":"Ophthalmol Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000510959","article-title":"Granulomatosis with polyangiitis with ocular manifestations","volume":"12","author":"Orazbekov","year":"2021","journal-title":"Case Rep Ophthalmol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.5858\/arpa.2013-0006-RS","article-title":"Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings","volume":"138","author":"Muller","year":"2014","journal-title":"Arch Pathol Lab Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00535-021-01784-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease 2020","volume":"56","author":"Nakase","year":"2021","journal-title":"J Gastroenterol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B113","doi-asserted-by":"crossref","first-page":"1756284819865142","DOI":"10.1177\/1756284819865142","article-title":"Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study","volume":"12","author":"Biedermann","year":"2019","journal-title":"Therap Adv Gastroenterol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/2050640620958902","article-title":"Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes","volume":"8","author":"Jansen","year":"2020","journal-title":"United Eur Gastroenterol J."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3748\/wjg.v23.i32.5836","volume":"23","author":"Troncoso","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"102944","DOI":"10.1016\/j.autrev.2021.102944","article-title":"Ocular involvement in monogenic autoinflammatory disease","volume":"20","author":"Maccora","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"11904","DOI":"10.1038\/s41598-021-91315-y","article-title":"Ocular manifestations in Chinese adult patients with NLRP3-associated autoinflammatory disease","volume":"11","author":"Meng","year":"2021","journal-title":"Sci Rep."},{"key":"B118","first-page":"44","article-title":"The eye involvement in monogenic autoinflammatory diseases: literature review and update","volume":"36","author":"Sota","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/jcm10010128","article-title":"Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?","volume":"10","author":"Welzel","year":"2021","journal-title":"J Clin Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/13816810.2012.695421","article-title":"Ocular manifestations of the autoinflammatory syndromes","volume":"33","author":"Tarabishy","year":"2012","journal-title":"Ophthalmic Genet."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.21203\/rs.3.rs-409833\/v1","article-title":"Ocular inflammatory diseases in children with familial Mediterranean fever: a true association or a coincidence?","volume":"42","author":"Avar-Aydin","year":"2022","journal-title":"Int Ophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000442216","article-title":"Choroidal thickness changes in the acute attack period in patients with familial mediterranean fever","volume":"235","author":"Gundogan","year":"2016","journal-title":"Ophthalmologica."},{"key":"B125","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","article-title":"A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry","volume":"12","author":"Papa","year":"2017","journal-title":"Orphanet J Rare Dis."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2515841419892056","DOI":"10.1177\/2515841419892056","article-title":"Comparison of optical coherence tomography angiography results of adult patients with Familial Mediterranean fever and healthy individuals","volume":"11","author":"Karaca","year":"2019","journal-title":"Ther Adv Ophthalmol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00296-020-04777-0","article-title":"Performance of diagnostic criteria in pediatric Behcet's disease","volume":"42","author":"Kurt","year":"2022","journal-title":"Rheumatol Int."},{"key":"B128","first-page":"130","article-title":"Reactive arthritis in children (review)","volume":"311","author":"Tugelbayeva","year":"2021","journal-title":"Georgian Med News"},{"key":"B129","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09273948.2016.1185527","volume":"25","author":"Pathanapitoon","year":"2017","journal-title":"Ocul Immunol Inflamm."},{"key":"B130","first-page":"964","article-title":"Ocular manifestations of systemic lupus erythematosus in children","volume":"24","author":"Al-Mayouf","year":"2003","journal-title":"Saudi Med J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaophthalmol.2015.2249","article-title":"Association of systemic lupus erythematosus with uveitis","volume":"133","author":"Gallagher","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sjopt.2016.02.001","article-title":"Ocular findings in systemic lupus erythematosus","volume":"30","author":"Shoughy","year":"2016","journal-title":"Saudi J Ophthalmol."},{"key":"B133","first-page":"259","article-title":"Pediatric uveitis","volume":"6","author":"Tugal-Tutkun","year":"2011","journal-title":"J Ophthalmic Vis Ries."},{"key":"B134","article-title":"Epidemiology and course of disease in childhood uveitis","volume-title":"Ophthalmology","author":"Smith","year":"2009"},{"key":"B135","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/09273940600557001","article-title":"Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis","volume":"14","author":"Soheilian","year":"2006","journal-title":"Ocul Immunol Inflamm."},{"key":"B136","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1076\/ocii.6.3.155.4041","article-title":"Vogt-Koyanagi-Harada syndrome in children","volume":"6","author":"Rathinam","year":"1998","journal-title":"Ocul Immunol Inflamm."},{"key":"B137","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/08820538.2021.1948067","article-title":"Vogt Koyanagi Harada disease in paediatric age group: clinical characteristics, remission, recurrences and complications in Asian Indian Population","volume":"37","author":"Kaza","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2016.05.002","article-title":"Vogt-Koyanagi-Harada disease","volume":"62","author":"O'Keefe","year":"2017","journal-title":"Surv Ophthalmol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3980\/j.issn.2222-3959.2014.06.18","article-title":"Uveitis associated with multiple sclerosis: complications and visual prognosis","volume":"7","author":"Kaya","year":"2014","journal-title":"Int J Ophthalmol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"Olsen","year":"2017","journal-title":"Surv Ophthalmol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/2008-322X.176897","article-title":"Pars planitis: epidemiology, clinical characteristics, management and visual prognosis","volume":"10","author":"Ozdal","year":"2015","journal-title":"J Ophthalmic Vis Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.autrev.2017.02.009","article-title":"Cogan's syndrome: State of the art of systemic immunosuppressive treatment in adult and pediatric patients","volume":"16","author":"Mora","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B144","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00296-006-0252-y","article-title":"A novel therapeutic option in Cogan diseases? TNF-alpha blockers","volume":"27","author":"Fricker","year":"2007","journal-title":"Rheumatol Int."},{"key":"B145","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-5-18","article-title":"Rituximab ameliorated severe hearing loss in Cogan's syndrome: a case report","volume":"5","author":"Orsoni","year":"2010","journal-title":"Orphanet J Rare Dis."},{"key":"B146","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/bcr-2014-206546","article-title":"Susac's syndrome: the value of fundus fluorescein angiography","volume":"2014","author":"Khan","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B147","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-0500-7-56","article-title":"Detection of branch retinal artery occlusions in Susac's syndrome","volume":"7","author":"Boukouvala","year":"2014","journal-title":"BMC Res Notes."},{"key":"B148","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.survophthal.2019.01.007","article-title":"A review and update on the ophthalmic implications of Susac syndrome","volume":"64","author":"Heng","year":"2019","journal-title":"Surv Ophthalmol."},{"key":"B149","first-page":"1729","article-title":"Susac syndrome\u2013clinical insight and strategies of therapy","volume":"19","author":"Grygiel-Gorniak","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40674-017-0057-z","article-title":"An update on treatment of pediatric chronic non-infectious uveitis","volume":"3","author":"Sood","year":"2017","journal-title":"Curr Treatm Opt Rheumatol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/jcm10132934","article-title":"Juvenile idiopathic arthritis-associated chronic uveitis: recent therapeutic approaches","volume":"10","author":"Quartier","year":"2021","journal-title":"J Clin Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","article-title":"Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study","volume":"120","author":"Gregory AC","year":"2013","journal-title":"Ophthalmology."},{"key":"B153","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ophtha.2020.01.036","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"127","author":"Thorne","year":"2020","journal-title":"Ophthalmology"},{"key":"B154","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/09273948.2013.824106","article-title":"Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids","volume":"22","author":"Shrestha","year":"2014","journal-title":"Ocul Immunol Inflamm."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/rheumatology\/key208","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology."},{"key":"B156","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/art.42036","article-title":"2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging","volume":"74","author":"Onel","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jaapos.2019.08.280","article-title":"The effect of patient compliance on remission rates in pediatric noninfectious uveitis","volume":"23","author":"Ashkenazy","year":"2019","journal-title":"J AAPOS"},{"key":"B158","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/QCO.0b013e328345d666","article-title":"Preventing varicella in children with malignancies: what is the evidence?","volume":"24","author":"Fisher","year":"2011","journal-title":"Curr Opin Infect Dis."},{"key":"B159","doi-asserted-by":"publisher","first-page":"101016","DOI":"10.1016\/j.pmedr.2019.101016","article-title":"Varicella-zoster virus post-exposure management and prophylaxis: a review","volume":"16","author":"Lachiewicz","year":"2019","journal-title":"Prev Med Rep."},{"key":"B160","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bulcan.2021.11.016","article-title":"Varicella post-exposure management for pediatric oncology patients","volume":"109","author":"Costa","year":"2022","journal-title":"Bull Cancer."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/apa.15118","article-title":"Low complication rate in immunocompromised children with varicella-zoster virus infections in a single centre","volume":"109","author":"Shamriz","year":"2020","journal-title":"Acta Paediatr."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00431-021-04283-w","article-title":"Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review","volume":"181","author":"Keller","year":"2022","journal-title":"Eur J Pediatr."},{"key":"B163","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA."},{"key":"B167","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/thoraxjnl-2015-206825","article-title":"Lung sarcoidosis in children: update on disease expression and management","volume":"70","author":"Nathan","year":"2015","journal-title":"Thorax."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s10067-015-2870-9","article-title":"Childhood sarcoidosis: Louisiana experience","volume":"35","author":"Gedalia","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1183\/09031936.00011507","article-title":"Childhood sarcoidosis: long-term follow-up","volume":"31","author":"Milman","year":"2008","journal-title":"Eur Respir J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Rose","year":"2015","journal-title":"Rheumatology."},{"key":"B171","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11926-017-0670-8","article-title":"Autoinflammatory diseases with periodic fevers","volume":"19","author":"Sag","year":"2017","journal-title":"Curr Rheumatol Rep."},{"key":"B172","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13244-020-00889-0","article-title":"Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review","volume":"11","author":"Alsharief","year":"2020","journal-title":"Insights Imaging."},{"key":"B173","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11926-020-00944-1","article-title":"The many faces of a monogenic autoinflammatory disease: adenosine deaminase 2 deficiency","volume":"22","author":"Kendall","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B174","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ajkd.2017.11.013","article-title":"The syndrome of tubulointerstitial nephritis with uveitis (TINU)","volume":"72","author":"Clive","year":"2018","journal-title":"Am J Kidney Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/ndt\/gfab030","article-title":"Tubulointerstitial nephritis and uveitis syndrome: a systematic review","volume":"37","author":"Regusci","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"B176","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.rdc.2021.07.001","article-title":"Recent updates in juvenile spondyloarthritis","volume":"47","author":"Srinivasalu","year":"2021","journal-title":"Rheum Dis Clin North Am."},{"key":"B177","doi-asserted-by":"publisher","first-page":"e18139","DOI":"10.7759\/cureus.18139","article-title":"Reactive arthritis post-SARS-CoV-2","volume":"13","author":"Ouedraogo","year":"2021","journal-title":"Cureus."},{"key":"B178","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S2468-1253(21)00297-1","article-title":"Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases","volume":"7","author":"Guillo","year":"2022","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1212\/WNL.0000000000002881","article-title":"Pediatric acquired CNS demyelinating syndromes: features associated with multiple sclerosis","volume":"87","author":"Hintzen","year":"2016","journal-title":"Neurology"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00415-018-8835-6","article-title":"Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study","volume":"265","author":"de Mol","year":"2018","journal-title":"J Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"B182","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00431-017-2937-5","article-title":"Dissecting Kawasaki disease: a state-of-the-art review","volume":"176","author":"Dietz","year":"2017","journal-title":"Eur J Pediatr."},{"key":"B183","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.pcl.2012.03.013","article-title":"Pediatric vasculitis","volume":"59","author":"Weiss","year":"2012","journal-title":"Pediatr Clin North Am."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/rheumatology\/kem173","article-title":"Ocular manifestations of systemic lupus erythematosus","volume":"46","author":"Sivaraj","year":"2007","journal-title":"Rheumatology."},{"key":"B185","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups","volume":"29","author":"Massias","year":"2020","journal-title":"Lupus."},{"key":"B186","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12016-013-8406-7","article-title":"Cogan's syndrome\u2013clinical guidelines and novel therapeutic approaches","volume":"47","author":"Tayer-Shifman","year":"2014","journal-title":"Clin Rev Allergy Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s002960100123","article-title":"Cogan's syndrome in childhood","volume":"20","author":"Olfat","year":"2001","journal-title":"Rheumatol Int."},{"key":"B188","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/01658107.2020.1748062","article-title":"Susac's syndrome: an updated review","volume":"44","author":"Pereira","year":"2020","journal-title":"Neuroophthalmology."},{"key":"B189","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrneurol.2013.82","article-title":"Characteristics of Susac syndrome: a review of all reported cases","volume":"9","author":"Dorr","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jns.2007.01.036","article-title":"Susac's syndrome: 1975-2005 microangiopathy\/autoimmune endotheliopathy","volume":"257","author":"Susac","year":"2007","journal-title":"J Neurol Sci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"e5223","DOI":"10.1097\/MD.0000000000005223","article-title":"Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis","volume":"95","author":"Vishnevskia-Dai","year":"2016","journal-title":"Medicine."},{"key":"B192","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajo.2018.10.018","article-title":"Reclassifying idiopathic uveitis: lessons from a tertiary uveitis center","volume":"198","author":"Choi","year":"2019","journal-title":"Am J Ophthalmol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/09273948.2018.1522356","article-title":"Uveitis of unknown etiology: clinical and outcome features. A retrospective analysis of 355 patients","volume":"27","author":"Richard Colmant","year":"2019","journal-title":"Ocul Immunol Inflamm."},{"key":"B194","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"B195","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","article-title":"American College of Rheumatology\/Arthritis Foundation Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3899\/jrheum.130302","article-title":"Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry","volume":"40","author":"Angeles-Han","year":"2013","journal-title":"J Rheumatol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B198","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/17469899.2019.1663731","article-title":"Update on the management of uveitis in children: an overview for the clinician","volume":"14","author":"Kim","year":"2019","journal-title":"Expert Rev Ophthalmol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","article-title":"Current therapeutic approaches to autoimmune chronic uveitis in children","volume":"9","author":"Simonini","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B200","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12969-016-0069-5","article-title":"Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry","volume":"14","author":"Henderson","year":"2016","journal-title":"Pediatr Rheumatol Online J."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology."},{"key":"B202","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajo.2011.10.008","article-title":"Efficacy and potential complications of difluprednate use for pediatric uveitis","volume":"153","author":"Slabaugh","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.ophtha.2014.05.021","article-title":"Periocular corticosteroid injections in uveitis: effects and complications","volume":"121","author":"Sen","year":"2014","journal-title":"Ophthalmology."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2147\/OPTH.S17419","article-title":"Dexamethasone intravitreal implant for the treatment of noninfectious uveitis","volume":"5","author":"Hunter","year":"2011","journal-title":"Clin Ophthalmol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/09273948.2016.1142573","article-title":"Occurrence of and risk factors for ocular hypertension and secondary glaucoma in juvenile idiopathic arthritis-associated uveitis","volume":"25","author":"Stroh","year":"2017","journal-title":"Ocul Immunol Inflamm."},{"key":"B206","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4155\/tde-2019-0024","article-title":"Dexamethasone intravitreal implant (OZURDEX((R))) for macular edema secondary to noninfectious uveitis: a review of the literature","volume":"10","author":"Massa","year":"2019","journal-title":"Ther Deliv."},{"key":"B207","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv Transl Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"CD010126","DOI":"10.1002\/14651858.CD010126.pub2","article-title":"Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth","volume":"6","author":"Axelsson","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"B209","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S2213-2600(14)70024-4","article-title":"Inhaled corticosteroids in children: effects on bone mineral density and growth","volume":"2","author":"Fuhlbrigge","year":"2014","journal-title":"Lancet Respir Med."},{"key":"B210","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review","volume":"39","author":"Rice","year":"2017","journal-title":"Clin Ther."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00296-014-3022-2","article-title":"Growth abnormalities in children and adolescents with juvenile idiopathic arthritis","volume":"34","author":"Bechtold","year":"2014","journal-title":"Rheumatol Int."},{"key":"B212","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semarthrit.2017.11.002","article-title":"Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS)","volume":"48","author":"McErlane","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"B213","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.crohns.2011.09.004","article-title":"The effects of anti-TNF-alpha treatment with adalimumab on growth in children with Crohn's disease (CD)","volume":"6","author":"Malik","year":"2012","journal-title":"J Crohns Colitis."},{"key":"B214","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MIB.0000000000001021","article-title":"Long-term efficacy and safety of adalimumab in pediatric patients with Crohn's Disease","volume":"23","author":"Faubion","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"B215","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","article-title":"Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis","volume":"151","author":"Kalinina Ayuso","year":"2011","journal-title":"Am J Ophthalmol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"B217","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s40744-021-00296-x","article-title":"Efficacy and safety of anti-TNFalpha therapy for uveitis associated with juvenile idiopathic arthritis: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2021","journal-title":"Rheumatol Ther."},{"key":"B218","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ophtha.2013.07.019","article-title":"Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up","volume":"121","author":"Kruh","year":"2014","journal-title":"Ophthalmology."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.39667","article-title":"Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the french uveitis network","volume":"68","author":"Vallet","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa1614160","article-title":"Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis","volume":"376","author":"Ramanan","year":"2017","journal-title":"N Engl J Med."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2017-212089","article-title":"ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis","volume":"77","author":"Quartier","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B222","first-page":"301","article-title":"Efficacy of anti-tumour necrosis factor-alpha monoclonal antibodies in patients with non-infectious anterior uveitis","volume":"37","author":"Fabiani","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fmed.2019.00104","article-title":"Anti-TNF drugs for chronic uveitis in adults-A systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Leal","year":"2019","journal-title":"Front Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1136\/bjophthalmol-2018-312767","article-title":"Long-term efficacy and tolerability of TNFalpha inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study","volume":"105","author":"Sharma","year":"2021","journal-title":"Br J Ophthalmol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/09273948.2016.1236968","article-title":"Efficacy of anti-TNF-alpha therapy for the treatment of non-infectious uveitis: a retrospective study of 21 patients","volume":"26","author":"Mercier","year":"2018","journal-title":"Ocul Immunol Inflamm."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/imj.14215","article-title":"The use of biologic agents in the management of uveitis","volume":"49","author":"Trivedi","year":"2019","journal-title":"Intern Med J."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology."},{"key":"B228","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B229","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12969-021-00630-1","article-title":"Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab","volume":"19","author":"Lanz","year":"2021","journal-title":"Pediatr Rheumatol Online J."},{"key":"B230","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B231","first-page":"680","article-title":"Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis","volume":"37","author":"Tosi","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/rheumatology\/keaa595","article-title":"Changing evidence over time: updated meta-analysis regarding anti-TNF efficacy in childhood chronic uveitis","volume":"60","author":"Maccora","year":"2021","journal-title":"Rheumatology."},{"key":"B233","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13075-020-02326-5","article-title":"Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry","volume":"22","author":"Armaroli","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"B234","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/rheumatology\/keab641","article-title":"Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries","volume":"61","author":"Kearsley-Fleet","year":"2022","journal-title":"Rheumatology."},{"key":"B235","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22649","article-title":"Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database","volume":"68","author":"Tappeiner","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B236","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00417-018-3928-6","article-title":"The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies","volume":"256","author":"Deitch","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaapos.2015.12.006","article-title":"Treatment of pediatric uveitis with adalimumab: the MERSI experience","volume":"20","author":"Castiblanco","year":"2016","journal-title":"J AAPOS."},{"key":"B238","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3899\/jrheum.160672","article-title":"Tumor necrosis factor inhibitors provide longterm clinical benefits in pediatric and young adult patients with blau syndrome","volume":"44","author":"Nagakura","year":"2017","journal-title":"J Rheumatol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40123-021-00387-6","article-title":"Role of adalimumab biosimilar in the treatment of non-anterior uveitis associated with Behcet's syndrome","volume":"10","author":"Sota","year":"2021","journal-title":"Ophthalmol Ther."},{"key":"B240","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10792-016-0293-5","article-title":"Adalimumab for the treatment of refractory noninfectious paediatric uveitis","volume":"37","author":"Munoz-Gallego","year":"2017","journal-title":"Int Ophthalmol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10787-020-00697-4","article-title":"Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behcet's syndrome","volume":"28","author":"Silvestri","year":"2020","journal-title":"Inflammopharmacology."},{"key":"B242","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.2147\/OPTH.S322445","article-title":"Biological therapy in noninfectious pediatric uveitis: a systematic review","volume":"15","author":"Norcia","year":"2021","journal-title":"Clin Ophthalmol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fphar.2020.00655","article-title":"New pharmacological strategies for the treatment of non-infectious uveitis. A minireview","volume":"11","author":"Valenzuela","year":"2020","journal-title":"Front Pharmacol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","article-title":"Anti-TNF-alpha versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network","volume":"129","author":"Leclercq","year":"2022","journal-title":"Ophthalmology."},{"key":"B245","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/S2665-9913(20)30008-4","article-title":"Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial","volume":"2","author":"Ramanan","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/rheumatology\/kex480","article-title":"Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behcet's disease: multicentre retrospective study","volume":"57","author":"Atienza-Mateo","year":"2018","journal-title":"Rheumatology."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/rheumatology\/kez030","article-title":"Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis","volume":"58","author":"Doeleman","year":"2019","journal-title":"Rheumatology."},{"key":"B248","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/1744666X.2019.1630273","article-title":"Therapeutic drug monitoring with biologic agents in immune mediated inflammatory diseases","volume":"15","author":"Papamichael","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/rheumatology\/keab354","article-title":"Association of adalimumab trough concentrations and treatment response in patients with juvenile idiopathic arthritis","volume":"61","author":"Doeleman","year":"2021","journal-title":"Rheumatology."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1759720X211002685","DOI":"10.1177\/1759720X211002685","article-title":"Impact of immunogenicity on clinical efficacy and toxicity profile of biologic agents used for treatment of inflammatory arthritis in children compared to adults","volume":"13","author":"Parikh","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B251","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/rheumatology\/kez285","article-title":"Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review","volume":"59","author":"Verstegen","year":"2020","journal-title":"Rheumatology."},{"key":"B252","article-title":"Effectiveness and safety of high-dose biologics in juvenile idiopathic arthritis in the childhood arthritis and rheumatology research alliance","volume-title":"Arthritis Care Res.","author":"Correll","year":"2021"},{"key":"B253","first-page":"1043","article-title":"Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis","volume":"35","author":"Leinonen","year":"2017","journal-title":"Clin Exp Rheumatol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/archdischild-2018-315060","article-title":"Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis","volume":"104","author":"Skrabl-Baumgartner","year":"2019","journal-title":"Arch Dis Child."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1001\/jama.2021.4172","article-title":"Effect of therapeutic drug monitoring vs. standard therapy during infliximab induction on disease remission in patients with chronic immune-mediated inflammatory diseases: a randomized clinical trial","volume":"325","author":"Syversen","year":"2021","journal-title":"JAMA."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2324400","DOI":"10.1155\/2021\/2324400","article-title":"Role of Janus Kinase (JAK) inhibitor in autoimmune ocular inflammation: a systematic review","volume":"2021","author":"Wen","year":"2021","journal-title":"J Immunol Res."},{"key":"B257","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s13063-021-05651-5","article-title":"Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)","volume":"22","author":"Ramanan","year":"2021","journal-title":"Trials."},{"key":"B258","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1093\/rheumatology\/keab116","article-title":"JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study","volume":"60","author":"Le Voyer","year":"2021","journal-title":"Rheumatology."},{"key":"B259","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J Clin Invest."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet."},{"key":"B261","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1186\/s13063-020-04796-z","article-title":"Discontinuing adalimumab in patients with controlled juvenileidiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial","volume":"21","author":"Acharya","year":"2020","journal-title":"Trials."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/acr.20524","article-title":"Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis","volume":"63","author":"Angeles-Han","year":"2011","journal-title":"Arthritis Care Res."},{"key":"B263","article-title":"Comprehensive assessment of quality of life, functioning and mental health in children with juvenile idiopathic arthritis and non-infectious uveitis","volume-title":"Arthritis Care Res.","author":"McDonald","year":"2021"},{"key":"B264","doi-asserted-by":"publisher","first-page":"xvi","DOI":"10.1016\/j.ajo.2018.03.028","article-title":"Chronic anterior uveitis in children: psychosocial challenges for patients and their families","volume":"191","author":"Parker","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B265","doi-asserted-by":"crossref","DOI":"10.1080\/09273948.2021.1976215","article-title":"Temporal Trends in childhood uveitis: using administrative health data to investigate the impact of health policy and clinical practice","volume-title":"Ocul Immunol Inflamm","author":"Narayan","year":"2021"},{"key":"B266","doi-asserted-by":"publisher","first-page":"e000819","DOI":"10.1136\/bmjophth-2021-000819","article-title":"Adalimumab in patients with vision-threatening uveitis: real-world clinical experience","volume":"6","author":"Tang Lee Say","year":"2021","journal-title":"BMJ Open Ophthalmol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.874711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:38:44Z","timestamp":1659332324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.874711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":266,"alternative-id":["10.3389\/fped.2022.874711"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.874711","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"article-number":"874711"}}